Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
TEVA: Teva Pharmaceutical Industries Limited Stock Analysis | finqOS
Healthcare · Drug Manufacturers - Specialty & Generic
The Story
TEVA
The Story
TEVA
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+4.3% / yr
Operating margin
17.2%
ROIC
10.4%
Financially safe
Adequate
Debt / equity
2.18×
Interest coverage
3.4×
Current ratio
0.88×
Valuation
Unrated
P/E ratio
55.6×
Teva Pharmaceutical Industries Limited
TEVA
New York Stock Exchange
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Teva Pharmaceutical Industries Limited
TEVA
New York Stock Exchange
·
USD
·
Closed
$35.01
−1.13%
$35.01
−$0.40 (1.13%)
52W Range
90th
pctl
Volume
0.78×
avg
Mkt Cap
40.77B
USD
P/E
55.6
TTM
Div Yield
–
ann
52W Range
90th
pctl
Volume
0.78×
avg
Market Cap
40.77B
USD
P/E Ratio
55.6
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings